Ozempic vs Wegovy
A side-by-side look at Ozempic and Wegovy, two prescription medications advertised on TV. Informational only — not medical advice.
| US Ozempic | US Wegovy | |
|---|---|---|
| Generic name | semaglutide | semaglutide |
| Drug class | GLP-1 Receptor Agonist | GLP-1 Receptor Agonist |
| Treats | Type 2 diabetes | Chronic weight management, cardiovascular risk reduction |
| Category | Diabetes | Weight Management |
| Manufacturer | Novo Nordisk | Novo Nordisk |
| Year approved | 2017 | 2021 |
| FDA warning | Moderate warnings | Black box warning |
| Est. TV ad spend | $420M | $380M |
| Common side effects | Nausea, Vomiting, Diarrhea, Abdominal pain | Nausea, Diarrhea, Vomiting, Constipation |
Frequently asked questions
Is Ozempic or Wegovy better?
Neither is universally "better." Ozempic (semaglutide) is used for type 2 diabetes, while Wegovy (semaglutide) is used for chronic weight management, cardiovascular risk reduction, but the right choice depends on your medical history, insurance and your doctor's guidance. This comparison is informational only.
What's the difference between Ozempic and Wegovy?
Ozempic is a GLP-1 Receptor Agonist made by Novo Nordisk, while Wegovy is a GLP-1 Receptor Agonist made by Novo Nordisk. See the table above for a side-by-side breakdown.
Which one spends more on TV ads?
Ozempic has the larger estimated TV advertising budget of the two.